Tetrasubstituted pyrazinones derived from the reaction of praziquantel with N-bromosuccinimide.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Tetrahedron Letters

• Publication date

  2014-08-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.TETLET.2014.06.083PMID 25125709PMCID PMC4128413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).

  2014cited by this paper
• Praziquantel analogs with activity against juvenile Schistosoma mansoni.

  2010cited by this paper
• Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.

  2010cited by this paper
• Metabolite profiling of praziquantel and its analogs during the analysis of in vitro metabolic stability using information-dependent acquisition on a hybrid triple quadrupole linear ion trap mass spectrometer.

  2010cited by this paper
• Praziquantel derivatives I: Modification of the aromatic ring.

  2007cited by this paper
• Chemotherapy of schistosomiasis: present and future.

  2007cited by this paper
• Biotransformation of praziquantel by human cytochrome p450 3A4 (CYP 3A4).

  2006cited by this paper
• Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.

  2005cited by this paper
• Biomimetic oxidation of praziquantel catalysed by metalloporphyrins

  2005cited by this paper
• Virtual Computational Chemistry Laboratory – Design and Description

  2005cited by this paper
• Light and scanning electron microscopy studies on the effects of the enantiomers of praziquantel and its main metabolite onSchistosoma mansoni in vitro

  2004cited by this paper
• Unusual CC Bond Migration in 3‐Ylidene‐2,5‐piperazinediones

  2000cited by this paper
• Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates.

  1998cited by this paper
• Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

  1997cited by this paper
• Antischistosomal drugs: past, present ... and future?

  1995cited by this paper
• Uptake and effect of praziquantel and the major human oxidative metabolite, 4-hydroxypraziquantel, by Schistosoma japonicum.

  1991cited by this paper
• Synthesis and Properties of cis‐ and trans‐4‐Hydroxypraziquantel

  1991cited by this paper
• Spectral and Chemical Properties of Pyrazino‐[2,1‐a]‐isoquinolin‐4‐one Derivatives

  1989cited by this paper
• Praziquantel: mechanisms of anti-schistosomal activity.

  1985cited by this paper
• Metabolism of praziquantel in man

  1978cited by this paper
• A total synthesis of sporidesmin A.

  1973cited by this paper

• Three Heterocyclic Rings Fused (6-6-6)

  2020cites this paper
• Use of Bromine and Bromo-Organic Compounds in Organic Synthesis.

  2016cites this paper